Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 11.13 GBp
Change Today -0.125 / -1.11%
Volume 0.0
As of 11:30 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

lidco group plc (LID) Snapshot

Open
11.25 GBp
Previous Close
11.25 GBp
Day High
11.25 GBp
Day Low
11.13 GBp
52 Week High
05/6/14 - 22.50 GBp
52 Week Low
02/11/15 - 5.38 GBp
Market Cap
21.6M
Average Volume 10 Days
49.6K
EPS TTM
0.0017 GBp
Shares Outstanding
194.2M
EX-Date
--
P/E TM
65.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for LIDCO GROUP PLC (LID)

Related News

No related news articles were found.

lidco group plc (LID) Related Businessweek News

No Related Businessweek News Found

lidco group plc (LID) Details

LiDCO Group Plc develops, manufactures, and sells cardiac monitoring equipment in the United Kingdom, the United States, Continental Europe, Japan, and internationally. It offers LiDCOplus, a computer-based platform monitor, which is used in the intensive care unit for real-time continuous display of hemodynamic parameters, such as cardiac output, oxygen delivery, and fluid-volume responsiveness; and LiDCOrapid, a cardiac output monitor for use in the operating theatre for fluid and drug management. The company also provides LiDCOview, an easy-to-use graphical display of historical data that is used for research and education purposes; and LiDCOrapidv2 with Unity software, which is designed for multi-parameter monitoring of anesthesia and fluids. It sells its products through direct sales and a network of distributors. The company was founded in 1991 and is headquartered in London, the United Kingdom.

50 Employees
Last Reported Date: 04/1/15
Founded in 1991

lidco group plc (LID) Top Compensated Officers

Co-Founder, Chief Executive Officer, Executiv...
Total Annual Compensation: 221.0K GBP
Co-Founder and Member of Clinical Advisory Bo...
Total Annual Compensation: --
Finance Director and Executive Director
Total Annual Compensation: 159.0K GBP
Compensation as of Fiscal Year 2015.

lidco group plc (LID) Key Developments

LiDCO Group plc Announces LIDCOrapid v2 Cleared for Sale in Japan

LiDCO Group Plc announced the LiDCOrapidv2 with Unity software and continuous non-invasive blood pressure module have been cleared for sale in Japan. LiDCO's Unity software allows the connection of LiDCO's continuous non-invasive blood pressure monitoring module. Existing LiDCOrapid monitors can be easily upgraded to provide the new functionality. LiDCO believes that the availability of the company's Unity software and continuous non-invasive blood pressure module will double the numbers of surgery patients suitable for monitoring with LiDCO's technology.

LiDCO Group plc Reports Audited Consolidated Earnings Results for the Year Ended January 31, 2015; Provides Earnings Guidance for the Year 2015

LiDCO Group Plc reported audited consolidated earnings results for the year ended January 31, 2015. For the year, the company reported revenue of £8,267,000 against £8,631,000 a year ago. Profit from operations was £243,000 against £235,000 a year ago. Profit before tax was £238,000 against £217,000 a year ago. Profit and total comprehensive income for the year attributable to equity holders of the parent was £343,000 or 0.18 pence per basic and diluted share against £299,000 or 0.15 pence per basic and diluted share a year ago. Net cash inflow from operating activities was £274,000 against £1,566,000 a year ago. Purchase of property, plant & equipment were £363,000 against £342,000 a year ago. Purchase of intangible assets was £635,000 against £723,000 a year ago. EBITDA for the year was £817,000 against £933,000 a year ago. The company expects 2015 to be its third successive year of profits. The company is well resourced and organised for further growth in the UK and expect export sales to advance again as it improve its access through additional distribution arrangements.

LiDCO Group Plc Showcases Portable LiDCO Stand System at ISICEM Brussels

LiDCO Group Plc announced that the company will be attending the International Symposium on Intensive Care and Emergency Medicine ('ISICEM') and will be showcasing its new portable LiDCO Battery Monitor Stand System ('BMSS') for the first time. LiDCO will be showcasing the company's products along with its new portable LiDCO BMSS at stand 1.07 -1.08 throughout the trade show which is being held on 17 March 2015 through till 20 March 2015. The portability of LiDCO's BMSS when combined with the existing non-invasive functionality creates many benefits for users of LiDCO's technology. The LiDCOrapid monitor can now be used mains free on battery power for up to six hours allowing it to be moved to different locations in the hospital where mains power might not be easily available. It can be used in pre-anaesthesia rooms to monitor fluid and drug requirements after anaesthetic induction and then keep continuously monitoring the patient as they are moved to the operating room. It can accompany the patient from the operating room to the post-operative recovery or intensive care ward, allowing practitioners a continuous hemodynamic monitoring record of both the surgery and recovery periods on a single monitor. It also allows it to be used within A&E as it can be more easily moved to assess and screen shock patients potentially requiring fluid resuscitation. The LiDCO BMSS received the certification required by the medical standard IEC 60601-1 (a series of technical standards for the safety and effectiveness of medical electrical equipment) on 13 March 2015. The development of the BMSS will allow LiDCO access to even more patients that need real-time hemodynamic monitoring, helping to reduce morbidity and complications, length of stay in hospital and overall costs associated with major surgery.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LID:LN 11.13 GBp -0.125

LID Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Deltex Medical Group PLC 6.13 GBp 0.00
Edwards Lifesciences Corp $127.75 USD +0.56
ICU Medical Inc $85.47 USD +0.50
Masimo Corp $34.60 USD +0.43
Pulsion Medical Systems SE €24.30 EUR 0.00
View Industry Companies
 

Industry Analysis

LID

Industry Average

Valuation LID Industry Range
Price/Earnings 63.3x
Price/Sales 2.6x
Price/Book 2.8x
Price/Cash Flow 29.9x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIDCO GROUP PLC, please visit www.lidco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.